$243.47
-1.20 (-0.49%)

Key Metrics

Market Cap
$23.90B
P/E Ratio
33.96
EPS
$7.17
Beta
N/A
Dividend Yield
N/A
ROE
10.21%
Current Ratio
2.37

Company Information

Industry
Medical Devices

About STERIS plc

STERIS plc provides infection prevention and other procedural products and services worldwide It operates through four segments Healthcare Applied Sterilization Technologies Life Sciences and Dental The Healthcare segment offers cleaning chemistries and sterility assurance products automated endoscope reprocessing system and tracking products accessories for gastrointestinal GI procedures washers sterilizers and other pieces of capital equipment for the operation of a sterile processing department and equipment used directly in the operating room including surgical tables lights and connectivity solutions as well as equipment management services It also provides capital equipment installation maintenance upgradation repair and troubleshooting services preventive maintenance programs and repair services instrument and endoscope repair and maintenance services and custom process improvement consulting and outsourced instrument sterile processing services The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities The Life Sciences segment designs manufactures and sells consumable products such as formulated cleaning chemistries barrier and sterility assurance products steam and vaporized hydrogen peroxide sterilizers and washer disinfectors This segment also offers equipment installation maintenance upgradation repair and troubleshooting services and preventive maintenance programs and repair services The Dental segment provides hand and powered dental instruments infection control products personal protective equipment and water quality products for dental suite The company serves its products and services to hospitals other healthcare providers and pharmaceutical manufacturers The company was founded in 1985 and is based in Dublin Ireland

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2026-02-04 $2.53 $2.53 +0.0%
2025-11-05 $2.47 $2.35 +5.1%
2025-08-06 $2.34 $2.26 +3.5%
2025-05-14 $2.74 $2.60 +5.4%

Financial Ratios (TTM)

Gross Margin
44.29%
Operating Margin
17.11%
Net Margin
12.07%
ROA
6.61%
Price to Book
3.69
Price to Sales
4.54